<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01611220</url>
  </required_header>
  <id_info>
    <org_study_id>USL22#03/12-CEP329</org_study_id>
    <nct_id>NCT01611220</nct_id>
  </id_info>
  <brief_title>Dissonance Inpatient Relapse Prevention Program for Anorexia Nervosa</brief_title>
  <acronym>RePAN</acronym>
  <official_title>Dissonance Inpatient Relapse Prevention Program for Anorexia Nervosa: A Randomized Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Villa Garda Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Villa Garda Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anorexia Nervosa inpatient treatment has often a short-term success as weight is restored to
      a healthy level, but high percentage of patients relapse during the first year following the
      discharge. The development of strategies to overcome this problem represents a priority for
      clinicians. Aim of this trial is to evaluate the effects of a relapse prevention program
      based on cognitive dissonance theory developed for hospitalized patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inpatient treatment for anorexia nervosa is often successful in restoring body weight, but a
      high percentage of patients relapse following discharge. The aim of the study was to assess
      the effect of a relapse prevention program during the last phase of inpatient treatment.
      Patients, when they achieve a BMI of 18.5, are randomly allocated to complete the standard
      cognitive behavior inpatient treatment (CBT-I) or to complete the standard CBT-I plus eight
      relapse prevention groups based on the cognitive dissonance. The intervention has been
      derived by the selective and indicated prevention programs using a dissonance-based approach.
      This intervention showed to be effective in reducing the risk for eating pathology onset. The
      primary outcome of the study is to assess the number of patients allocated to the two
      condition with a BMI equal or greater than 18.5 at 12-months after discharge.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2012</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body Mass Index (BMI)</measure>
    <time_frame>1 year</time_frame>
    <description>The main outcome is to assess the number of patients with good BMI outcome (BMI ≥ 18.5) at 12-month follow-up end in the two arm conditions.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Eating disorder Examination (EDE)</measure>
    <time_frame>1 year</time_frame>
    <description>Number of patients with &quot;full remission&quot; defined as having a global EDE score below 1SD above the community mean (1.74) and a BMI ≥ 18.5.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Anorexia Nervosa</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard cognitive behavior inpatient treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RePAN</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard cognitive behavior inpatient treatment plus 8 dissonance relapse prevention groups</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>RePAN</intervention_name>
    <description>The dissonance relapse prevention intervention consists of eight groups conducted by a psychologist who involves participants in interactive activities aimed to prevent relapse after discharge from the inpatient treatment</description>
    <arm_group_label>RePAN</arm_group_label>
    <other_name>Dissonance relapse prevention</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female

          -  Body Mass Index ≥ 18.5

          -  Anorexia Nervosa patients admitted to inpatient treatment

          -  Written informed consent

        Exclusion Criteria:

          -  Male

          -  Schizophrenia or other psychiatric disorders

          -  Substance abuse

          -  Medical complication that may hamper the interpretation of results (medical condition
             that causes weight changes)

          -  Absence of medical treatment (drugs) that may hamper the interpretation of results

          -  Pregnancy or plan to get pregnant
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Riccardo Dalle Grave, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Eating and Weight Disorders, Villa Garda Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Riccardo Dalle Grave, MD</last_name>
    <phone>0039 3484120680</phone>
    <phone_ext>0039</phone_ext>
    <email>rdalleg@tin.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elisa Chignola, Psych</last_name>
    <phone>0039 3402780196</phone>
    <phone_ext>0039</phone_ext>
    <email>elisachignola@yahoo.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Villa Garda Hospital</name>
      <address>
        <city>Garda</city>
        <state>Verona</state>
        <zip>37016</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Riccardo Dalle Grave, MD</last_name>
      <phone>0039 3484120680</phone>
      <phone_ext>0039</phone_ext>
      <email>r.dalleg@tin.it</email>
    </contact>
    <contact_backup>
      <last_name>Elisa Chignola, Psych</last_name>
      <phone>0039 3402780196</phone>
      <phone_ext>0039</phone_ext>
      <email>elisachignola@yahoo.it</email>
    </contact_backup>
    <investigator>
      <last_name>Riccardo Dalle Grave, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Stice E, Marti CN, Spoor S, Presnell K, Shaw H. Dissonance and healthy weight eating disorder prevention programs: long-term effects from a randomized efficacy trial. J Consult Clin Psychol. 2008 Apr;76(2):329-40. doi: 10.1037/0022-006X.76.2.329.</citation>
    <PMID>18377128</PMID>
  </reference>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 25, 2012</study_first_submitted>
  <study_first_submitted_qc>May 30, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 4, 2012</study_first_posted>
  <last_update_submitted>December 7, 2015</last_update_submitted>
  <last_update_submitted_qc>December 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Villa Garda Hospital</investigator_affiliation>
    <investigator_full_name>Riccardo Dalle Grave</investigator_full_name>
    <investigator_title>Head of Department of Eating and Weight Disorders</investigator_title>
  </responsible_party>
  <keyword>Anorexia Nervosa</keyword>
  <keyword>Relapse prevention</keyword>
  <keyword>Cognitive Dissonance</keyword>
  <keyword>Inpatient treatment</keyword>
  <keyword>Cognitive behavior therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Recurrence</mesh_term>
    <mesh_term>Anorexia</mesh_term>
    <mesh_term>Anorexia Nervosa</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

